APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biopharmaceutical Process Development Services

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Biopharmaceutical Process Development Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

16 January 2026192 pages

Choose your research edition.

Industry ResearchBiopharmaceutical Process Development Services Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Biopharmaceutical Process Development Services Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Biopharmaceutical Process Development Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biopharmaceutical Process Development Services Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Biopharmaceutical Process Development Services Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Biopharmaceutical Process Development Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Biopharmaceutical Process Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biopharmaceutical Process Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biopharmaceutical Process Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Biopharmaceutical Process Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biopharmaceutical Process Development Services include Merck Millipore, Cytiva, Coriolis Pharma, Lonza, Premas Biotech, Kemwell Biopharma, Avantor, Pace Life Sciences and KBI Biopharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Biopharmaceutical Process Development Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biopharmaceutical Process Development Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biopharmaceutical Process Development Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Biopharmaceutical Process Development Services market size, projected growth trends, production technologies, key applications, and end-use industries.

Biopharmaceutical Process Development Services Segment by Company

Merck Millipore

Cytiva

Coriolis Pharma

Lonza

Premas Biotech

Kemwell Biopharma

Avantor

Pace Life Sciences

KBI Biopharma

Rommelag

FyoniBio

Rentschler Biopharma SE

BioPharma Services

GenIbet

Biopharmaceutical Process Development Services Segment by Type

Cell Culture

Upstream Process Development

Downstream Process Development

Biopharmaceutical Process Development Services Segment by Application

Small and Medium Enterprises

Large Enterprises

Biopharmaceutical Process Development Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical Process Development Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical Process Development Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical Process Development Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biopharmaceutical Process Development Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biopharmaceutical Process Development Services industry.

Chapter 3: Detailed analysis of Biopharmaceutical Process Development Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biopharmaceutical Process Development Servicesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biopharmaceutical Process Development Services Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Cell Culture Table 3. Key Players of Upstream Process Development Table 4. Key Players of Downstream Process Development Table 4. Global Biopharmaceutical Process Development Services Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Small and Medium Enterprises Table 6. Key Players of Large Enterprises Table 7. Global Biopharmaceutical Process Development Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Biopharmaceutical Process Development Services Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Biopharmaceutical Process Development Services Market Share by Region (2021-2026) Table 10. Global Biopharmaceutical Process Development Services Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Biopharmaceutical Process Development Services Market Share by Region (2027-2032) Table 12. Biopharmaceutical Process Development Services Industry Trends Table 13. Biopharmaceutical Process Development Services Industry Drivers Table 14. Biopharmaceutical Process Development Services Industry Opportunities and Challenges Table 15. Biopharmaceutical Process Development Services Industry Restraints Table 16. Global Biopharmaceutical Process Development Services Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Biopharmaceutical Process Development Services Revenue Market Share by Company (2021-2026) Table 18. Global Biopharmaceutical Process Development Services Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Biopharmaceutical Process Development Services Key Company Head Office and Area Served Table 20. Global Biopharmaceutical Process Development Services Company, Product Type & Application Table 21. Global Biopharmaceutical Process Development Services Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Biopharmaceutical Process Development Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Biopharmaceutical Process Development Services Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Biopharmaceutical Process Development Services Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Biopharmaceutical Process Development Services Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Biopharmaceutical Process Development Services Revenue Market Share by Type (2021-2026) Table 28. Global Biopharmaceutical Process Development Services Revenue Market Share by Type (2027-2032) Table 29. Global Biopharmaceutical Process Development Services Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Biopharmaceutical Process Development Services Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Biopharmaceutical Process Development Services Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Biopharmaceutical Process Development Services Revenue Market Share by Application (2021-2026) Table 33. Global Biopharmaceutical Process Development Services Revenue Market Share by Application (2027-2032) Table 34. Merck Millipore Company Information Table 35. Merck Millipore Business Overview Table 36. Merck Millipore Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Merck Millipore Biopharmaceutical Process Development Services Product Portfolio Table 38. Merck Millipore Recent Development Table 39. Cytiva Company Information Table 40. Cytiva Business Overview Table 41. Cytiva Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Cytiva Biopharmaceutical Process Development Services Product Portfolio Table 43. Cytiva Recent Development Table 44. Coriolis Pharma Company Information Table 45. Coriolis Pharma Business Overview Table 46. Coriolis Pharma Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Coriolis Pharma Biopharmaceutical Process Development Services Product Portfolio Table 48. Coriolis Pharma Recent Development Table 49. Lonza Company Information Table 50. Lonza Business Overview Table 51. Lonza Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Lonza Biopharmaceutical Process Development Services Product Portfolio Table 53. Lonza Recent Development Table 54. Premas Biotech Company Information Table 55. Premas Biotech Business Overview Table 56. Premas Biotech Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Premas Biotech Biopharmaceutical Process Development Services Product Portfolio Table 58. Premas Biotech Recent Development Table 59. Kemwell Biopharma Company Information Table 60. Kemwell Biopharma Business Overview Table 61. Kemwell Biopharma Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Kemwell Biopharma Biopharmaceutical Process Development Services Product Portfolio Table 63. Kemwell Biopharma Recent Development Table 64. Avantor Company Information Table 65. Avantor Business Overview Table 66. Avantor Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Avantor Biopharmaceutical Process Development Services Product Portfolio Table 68. Avantor Recent Development Table 69. Pace Life Sciences Company Information Table 70. Pace Life Sciences Business Overview Table 71. Pace Life Sciences Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Pace Life Sciences Biopharmaceutical Process Development Services Product Portfolio Table 73. Pace Life Sciences Recent Development Table 74. KBI Biopharma Company Information Table 75. KBI Biopharma Business Overview Table 76. KBI Biopharma Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. KBI Biopharma Biopharmaceutical Process Development Services Product Portfolio Table 78. KBI Biopharma Recent Development Table 79. Rommelag Company Information Table 80. Rommelag Business Overview Table 81. Rommelag Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Rommelag Biopharmaceutical Process Development Services Product Portfolio Table 83. Rommelag Recent Development Table 84. FyoniBio Company Information Table 85. FyoniBio Business Overview Table 86. FyoniBio Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. FyoniBio Biopharmaceutical Process Development Services Product Portfolio Table 88. FyoniBio Recent Development Table 89. Rentschler Biopharma SE Company Information Table 90. Rentschler Biopharma SE Business Overview Table 91. Rentschler Biopharma SE Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Rentschler Biopharma SE Biopharmaceutical Process Development Services Product Portfolio Table 93. Rentschler Biopharma SE Recent Development Table 94. BioPharma Services Company Information Table 95. BioPharma Services Business Overview Table 96. BioPharma Services Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. BioPharma Services Biopharmaceutical Process Development Services Product Portfolio Table 98. BioPharma Services Recent Development Table 99. GenIbet Company Information Table 100. GenIbet Business Overview Table 101. GenIbet Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. GenIbet Biopharmaceutical Process Development Services Product Portfolio Table 103. GenIbet Recent Development Table 104. North America Biopharmaceutical Process Development Services Market Size by Type (2021-2026) & (US$ Million) Table 105. North America Biopharmaceutical Process Development Services Market Size by Type (2027-2032) & (US$ Million) Table 106. North America Biopharmaceutical Process Development Services Market Size by Application (2021-2026) & (US$ Million) Table 107. North America Biopharmaceutical Process Development Services Market Size by Application (2027-2032) & (US$ Million) Table 108. North America Biopharmaceutical Process Development Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. North America Biopharmaceutical Process Development Services Market Size by Country (2021-2026) Table 110. North America Biopharmaceutical Process Development Services Market Size by Country (2027-2032) Table 111. Europe Biopharmaceutical Process Development Services Market Size by Type (2021-2026) & (US$ Million) Table 112. Europe Biopharmaceutical Process Development Services Market Size by Type (2027-2032) & (US$ Million) Table 113. Europe Biopharmaceutical Process Development Services Market Size by Application (2021-2026) & (US$ Million) Table 114. Europe Biopharmaceutical Process Development Services Market Size by Application (2027-2032) & (US$ Million) Table 115. Europe Biopharmaceutical Process Development Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. Europe Biopharmaceutical Process Development Services Market Size by Country (2021-2026) Table 117. Europe Biopharmaceutical Process Development Services Market Size by Country (2027-2032) Table 118. China Biopharmaceutical Process Development Services Market Size by Type (2021-2026) & (US$ Million) Table 119. China Biopharmaceutical Process Development Services Market Size by Type (2027-2032) & (US$ Million) Table 120. China Biopharmaceutical Process Development Services Market Size by Application (2021-2026) & (US$ Million) Table 121. China Biopharmaceutical Process Development Services Market Size by Application (2027-2032) & (US$ Million) Table 122. Asia Biopharmaceutical Process Development Services Market Size by Type (2021-2026) & (US$ Million) Table 123. Asia Biopharmaceutical Process Development Services Market Size by Type (2027-2032) & (US$ Million) Table 124. Asia Biopharmaceutical Process Development Services Market Size by Application (2021-2026) & (US$ Million) Table 125. Asia Biopharmaceutical Process Development Services Market Size by Application (2027-2032) & (US$ Million) Table 126. Asia Biopharmaceutical Process Development Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Asia Biopharmaceutical Process Development Services Market Size by Country (2021-2026) Table 128. Asia Biopharmaceutical Process Development Services Market Size by Country (2027-2032) Table 129. South America, Middle East & Africa Biopharmaceutical Process Development Services Market Size by Type (2021-2026) & (US$ Million) Table 130. South America, Middle East & Africa Biopharmaceutical Process Development Services Market Size by Type (2027-2032) & (US$ Million) Table 131. South America, Middle East & Africa Biopharmaceutical Process Development Services Market Size by Application (2021-2026) & (US$ Million) Table 132. South America, Middle East & Africa Biopharmaceutical Process Development Services Market Size by Application (2027-2032) & (US$ Million) Table 133. South America, Middle East & Africa Biopharmaceutical Process Development Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. South America, Middle East & Africa Biopharmaceutical Process Development Services Market Size by Country (2021-2026) Table 135. South America, Middle East & Africa Biopharmaceutical Process Development Services Market Size by Country (2027-2032) Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Biopharmaceutical Process Development Services Product Image Figure 2. Global Biopharmaceutical Process Development Services Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Biopharmaceutical Process Development Services Market Share by Type: 2025 VS 2032 Figure 4. Cell Culture Image Figure 5. Upstream Process Development Image Figure 6. Downstream Process Development Image Figure 7. Global Biopharmaceutical Process Development Services Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Biopharmaceutical Process Development Services Market Share by Application: 2025 VS 2032 Figure 9. Small and Medium Enterprises Image Figure 10. Large Enterprises Image Figure 11. Global Biopharmaceutical Process Development Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 13. Global Biopharmaceutical Process Development Services Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Biopharmaceutical Process Development Services Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Biopharmaceutical Process Development Services Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Biopharmaceutical Process Development Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Biopharmaceutical Process Development Services Revenue Market Share by Type (2021-2032) Figure 20. Global Biopharmaceutical Process Development Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Biopharmaceutical Process Development Services Revenue Market Share by Application (2021-2032) Figure 22. North America Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 23. North America Biopharmaceutical Process Development Services Market Share by Type (2021-2032) Figure 24. North America Biopharmaceutical Process Development Services Market Share by Application (2021-2032) Figure 25. North America Biopharmaceutical Process Development Services Market Share by Country (2021-2032) Figure 26. United States Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 27. Canada Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 29. Europe Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 30. Europe Biopharmaceutical Process Development Services Market Share by Type (2021-2032) Figure 31. Europe Biopharmaceutical Process Development Services Market Share by Application (2021-2032) Figure 32. Europe Biopharmaceutical Process Development Services Market Share by Country (2021-2032) Figure 33. Germany Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 34. France Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 36. Italy Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 37. Russia Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 39. China Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 40. China Biopharmaceutical Process Development Services Market Share by Type (2021-2032) Figure 41. China Biopharmaceutical Process Development Services Market Share by Application (2021-2032) Figure 42. Asia Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 43. Asia Biopharmaceutical Process Development Services Market Share by Type (2021-2032) Figure 44. Asia Biopharmaceutical Process Development Services Market Share by Application (2021-2032) Figure 45. Asia Biopharmaceutical Process Development Services Market Share by Country (2021-2032) Figure 46. Japan Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 50. India Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 51. Australia Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Biopharmaceutical Process Development Services Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Biopharmaceutical Process Development Services Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Biopharmaceutical Process Development Services Market Share by Country (2021-2032) Figure 56. Brazil Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 61. UAE Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 63. Chile Biopharmaceutical Process Development Services Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Cell Culture
  • Upstream Process Development
  • Downstream Process Development
Applications
  • Small and Medium Enterprises
  • Large Enterprises
Companies covered
  • Merck Millipore
  • Cytiva
  • Coriolis Pharma
  • Lonza
  • Premas Biotech
  • Kemwell Biopharma
  • Avantor
  • Pace Life Sciences
  • KBI Biopharma
  • Rommelag
  • FyoniBio
  • Rentschler Biopharma SE
  • BioPharma Services
  • GenIbet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Biopharmaceutical Process Development Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Cell Culture
  5. 1.2.3 Upstream Process Development
  6. 1.2.4 Downstream Process Development
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Biopharmaceutical Process Development Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Small and Medium Enterprises
  10. 1.3.3 Large Enterprises
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Biopharmaceutical Process Development Services Growth Trends by Region
  13. 1.5.1 Global Biopharmaceutical Process Development Services Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Biopharmaceutical Process Development Services Market Size by Region (2021-2026)
  15. 1.5.3 Biopharmaceutical Process Development Services Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Biopharmaceutical Process Development Services Market Dynamics
  1. 2.1 Biopharmaceutical Process Development Services Industry Trends
  2. 2.2 Biopharmaceutical Process Development Services Industry Drivers
  3. 2.3 Biopharmaceutical Process Development Services Industry Opportunities and Challenges
  4. 2.4 Biopharmaceutical Process Development Services Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Biopharmaceutical Process Development Services Revenue by Company (2021-2026)
  2. 3.2 Global Biopharmaceutical Process Development Services Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Biopharmaceutical Process Development Services Key Company Head office and Area Served
  4. 3.4 Global Biopharmaceutical Process Development Services Company, Product Type & Application
  5. 3.5 Global Biopharmaceutical Process Development Services Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Biopharmaceutical Process Development Services Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Biopharmaceutical Process Development Services Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Biopharmaceutical Process Development Services Tier 1, Tier 2, and Tier 3
4 Biopharmaceutical Process Development Services Market by Type
  1. 4.1 Global Biopharmaceutical Process Development Services Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Biopharmaceutical Process Development Services Market Size by Type (2021-2032)
  3. 4.3 Global Biopharmaceutical Process Development Services Market Size Share by Type (2021-2032)
5 Biopharmaceutical Process Development Services Market by Application
  1. 5.1 Global Biopharmaceutical Process Development Services Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Biopharmaceutical Process Development Services Market Size by Application (2021-2032)
  3. 5.3 Global Biopharmaceutical Process Development Services Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Merck Millipore
  2. 6.1.1 Merck Millipore Company Information
  3. 6.1.2 Merck Millipore Business Overview
  4. 6.1.3 Merck Millipore Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Merck Millipore Biopharmaceutical Process Development Services Product Portfolio
  6. 6.1.5 Merck Millipore Recent Developments
  7. 6.2 Cytiva
  8. 6.2.1 Cytiva Company Information
  9. 6.2.2 Cytiva Business Overview
  10. 6.2.3 Cytiva Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Cytiva Biopharmaceutical Process Development Services Product Portfolio
  12. 6.2.5 Cytiva Recent Developments
  13. 6.3 Coriolis Pharma
  14. 6.3.1 Coriolis Pharma Company Information
  15. 6.3.2 Coriolis Pharma Business Overview
  16. 6.3.3 Coriolis Pharma Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Coriolis Pharma Biopharmaceutical Process Development Services Product Portfolio
  18. 6.3.5 Coriolis Pharma Recent Developments
  19. 6.4 Lonza
  20. 6.4.1 Lonza Company Information
  21. 6.4.2 Lonza Business Overview
  22. 6.4.3 Lonza Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Lonza Biopharmaceutical Process Development Services Product Portfolio
  24. 6.4.5 Lonza Recent Developments
  25. 6.5 Premas Biotech
  26. 6.5.1 Premas Biotech Company Information
  27. 6.5.2 Premas Biotech Business Overview
  28. 6.5.3 Premas Biotech Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Premas Biotech Biopharmaceutical Process Development Services Product Portfolio
  30. 6.5.5 Premas Biotech Recent Developments
  31. 6.6 Kemwell Biopharma
  32. 6.6.1 Kemwell Biopharma Company Information
  33. 6.6.2 Kemwell Biopharma Business Overview
  34. 6.6.3 Kemwell Biopharma Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Kemwell Biopharma Biopharmaceutical Process Development Services Product Portfolio
  36. 6.6.5 Kemwell Biopharma Recent Developments
  37. 6.7 Avantor
  38. 6.7.1 Avantor Company Information
  39. 6.7.2 Avantor Business Overview
  40. 6.7.3 Avantor Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Avantor Biopharmaceutical Process Development Services Product Portfolio
  42. 6.7.5 Avantor Recent Developments
  43. 6.8 Pace Life Sciences
  44. 6.8.1 Pace Life Sciences Company Information
  45. 6.8.2 Pace Life Sciences Business Overview
  46. 6.8.3 Pace Life Sciences Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Pace Life Sciences Biopharmaceutical Process Development Services Product Portfolio
  48. 6.8.5 Pace Life Sciences Recent Developments
  49. 6.9 KBI Biopharma
  50. 6.9.1 KBI Biopharma Company Information
  51. 6.9.2 KBI Biopharma Business Overview
  52. 6.9.3 KBI Biopharma Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 KBI Biopharma Biopharmaceutical Process Development Services Product Portfolio
  54. 6.9.5 KBI Biopharma Recent Developments
  55. 6.10 Rommelag
  56. 6.10.1 Rommelag Company Information
  57. 6.10.2 Rommelag Business Overview
  58. 6.10.3 Rommelag Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Rommelag Biopharmaceutical Process Development Services Product Portfolio
  60. 6.10.5 Rommelag Recent Developments
  61. 6.11 FyoniBio
  62. 6.11.1 FyoniBio Company Information
  63. 6.11.2 FyoniBio Business Overview
  64. 6.11.3 FyoniBio Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 FyoniBio Biopharmaceutical Process Development Services Product Portfolio
  66. 6.11.5 FyoniBio Recent Developments
  67. 6.12 Rentschler Biopharma SE
  68. 6.12.1 Rentschler Biopharma SE Company Information
  69. 6.12.2 Rentschler Biopharma SE Business Overview
  70. 6.12.3 Rentschler Biopharma SE Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Rentschler Biopharma SE Biopharmaceutical Process Development Services Product Portfolio
  72. 6.12.5 Rentschler Biopharma SE Recent Developments
  73. 6.13 BioPharma Services
  74. 6.13.1 BioPharma Services Company Information
  75. 6.13.2 BioPharma Services Business Overview
  76. 6.13.3 BioPharma Services Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 BioPharma Services Biopharmaceutical Process Development Services Product Portfolio
  78. 6.13.5 BioPharma Services Recent Developments
  79. 6.14 GenIbet
  80. 6.14.1 GenIbet Company Information
  81. 6.14.2 GenIbet Business Overview
  82. 6.14.3 GenIbet Biopharmaceutical Process Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 GenIbet Biopharmaceutical Process Development Services Product Portfolio
  84. 6.14.5 GenIbet Recent Developments
7 North America
  1. 7.1 North America Biopharmaceutical Process Development Services Market Size (2021-2032)
  2. 7.2 North America Biopharmaceutical Process Development Services Market Size by Type
  3. 7.2.1 North America Biopharmaceutical Process Development Services Market Size by Type (2021-2026)
  4. 7.2.2 North America Biopharmaceutical Process Development Services Market Size by Type (2027-2032)
  5. 7.2.3 North America Biopharmaceutical Process Development Services Market Share by Type (2021-2032)
  6. 7.3 North America Biopharmaceutical Process Development Services Market Size by Application
  7. 7.3.1 North America Biopharmaceutical Process Development Services Market Size by Application (2021-2026)
  8. 7.3.2 North America Biopharmaceutical Process Development Services Market Size by Application (2027-2032)
  9. 7.3.3 North America Biopharmaceutical Process Development Services Market Share by Application (2021-2032)
  10. 7.4 North America Biopharmaceutical Process Development Services Market Size by Country
  11. 7.4.1 North America Biopharmaceutical Process Development Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Biopharmaceutical Process Development Services Market Size by Country (2021-2026)
  13. 7.4.3 North America Biopharmaceutical Process Development Services Market Size by Country (2027-2032)
  14. 7.4.4 North America Biopharmaceutical Process Development Services Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Biopharmaceutical Process Development Services Market Size (2021-2032)
  2. 8.2 Europe Biopharmaceutical Process Development Services Market Size by Type
  3. 8.2.1 Europe Biopharmaceutical Process Development Services Market Size by Type (2021-2026)
  4. 8.2.2 Europe Biopharmaceutical Process Development Services Market Size by Type (2027-2032)
  5. 8.2.3 Europe Biopharmaceutical Process Development Services Market Share by Type (2021-2032)
  6. 8.3 Europe Biopharmaceutical Process Development Services Market Size by Application
  7. 8.3.1 Europe Biopharmaceutical Process Development Services Market Size by Application (2021-2026)
  8. 8.3.2 Europe Biopharmaceutical Process Development Services Market Size by Application (2027-2032)
  9. 8.3.3 Europe Biopharmaceutical Process Development Services Market Share by Application (2021-2032)
  10. 8.4 Europe Biopharmaceutical Process Development Services Market Size by Country
  11. 8.4.1 Europe Biopharmaceutical Process Development Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Biopharmaceutical Process Development Services Market Size by Country (2021-2026)
  13. 8.4.3 Europe Biopharmaceutical Process Development Services Market Size by Country (2027-2032)
  14. 8.4.4 Europe Biopharmaceutical Process Development Services Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Biopharmaceutical Process Development Services Market Size (2021-2032)
  2. 9.2 China Biopharmaceutical Process Development Services Market Size by Type
  3. 9.2.1 China Biopharmaceutical Process Development Services Market Size by Type (2021-2026)
  4. 9.2.2 China Biopharmaceutical Process Development Services Market Size by Type (2027-2032)
  5. 9.2.3 China Biopharmaceutical Process Development Services Market Share by Type (2021-2032)
  6. 9.3 China Biopharmaceutical Process Development Services Market Size by Application
  7. 9.3.1 China Biopharmaceutical Process Development Services Market Size by Application (2021-2026)
  8. 9.3.2 China Biopharmaceutical Process Development Services Market Size by Application (2027-2032)
  9. 9.3.3 China Biopharmaceutical Process Development Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Biopharmaceutical Process Development Services Market Size (2021-2032)
  2. 10.2 Asia Biopharmaceutical Process Development Services Market Size by Type
  3. 10.2.1 Asia Biopharmaceutical Process Development Services Market Size by Type (2021-2026)
  4. 10.2.2 Asia Biopharmaceutical Process Development Services Market Size by Type (2027-2032)
  5. 10.2.3 Asia Biopharmaceutical Process Development Services Market Share by Type (2021-2032)
  6. 10.3 Asia Biopharmaceutical Process Development Services Market Size by Application
  7. 10.3.1 Asia Biopharmaceutical Process Development Services Market Size by Application (2021-2026)
  8. 10.3.2 Asia Biopharmaceutical Process Development Services Market Size by Application (2027-2032)
  9. 10.3.3 Asia Biopharmaceutical Process Development Services Market Share by Application (2021-2032)
  10. 10.4 Asia Biopharmaceutical Process Development Services Market Size by Country
  11. 10.4.1 Asia Biopharmaceutical Process Development Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Biopharmaceutical Process Development Services Market Size by Country (2021-2026)
  13. 10.4.3 Asia Biopharmaceutical Process Development Services Market Size by Country (2027-2032)
  14. 10.4.4 Asia Biopharmaceutical Process Development Services Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Biopharmaceutical Process Development Services Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Biopharmaceutical Process Development Services Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Biopharmaceutical Process Development Services Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Biopharmaceutical Process Development Services Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Biopharmaceutical Process Development Services Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Biopharmaceutical Process Development Services Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Biopharmaceutical Process Development Services Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Biopharmaceutical Process Development Services Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Biopharmaceutical Process Development Services Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Biopharmaceutical Process Development Services Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Biopharmaceutical Process Development Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Biopharmaceutical Process Development Services Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Biopharmaceutical Process Development Services Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Biopharmaceutical Process Development Services Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst